ASCO25: MSD’s ADC candidate achieves 56.3% ORR in lymphoma trial
MSD confirmed a recommended dose has been identified as the Phase III portion continues enrolment.
ASCO25: Merck KGaA’s ADC shows safety and tolerability in colorectal cancer trial
Intellia stock dips following safety event in Phase III gene therapy trial
Biohaven initiates Phase II/III trial of BHV-8000 for early Parkinson’s
Alumis concludes enrolment in Phase III programme of plaque psoriasis therapy
Sibeprenlimab’s priority review highlights potential to differentiate in IgAN space
Analysis
View More
Themes
View MorePatient-centric approaches thrive on wearables and remote access in trials
Experts discuss the use of artificial intelligence (AI) and patient-centric strategies in oncology clinical trials.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
1 of 2
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal